We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+30.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$810M
AUM Growth
-$260M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$17.2M
2
+$16.8M
3
+$15.5M
4
ABT icon
Abbott
ABT
+$12.6M
5
WAY
Waystar Holding Corp
WAY
+$9.09M

Top Sells

1
+$22M
2
+$21.3M
3
+$19.7M
4
DHR icon
Danaher
DHR
+$17.2M
5
ALGN icon
Align Technology
ALGN
+$16M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCUL icon
76
Ocular Therapeutix
OCUL
$1.79B
$2.58M 0.32%
305,000
+40,000
STE icon
77
Steris
STE
$20.5B
$2.54M 0.31%
11,500
+5,500
VCEL icon
78
Vericel Corp
VCEL
$1.83B
$2.25M 0.28%
70,000
-47,000
KURA icon
79
Kura Oncology
KURA
$760M
$2.21M 0.27%
271,500
-600,500
CI icon
80
Cigna
CI
$76.6B
$2.13M 0.26%
8,000
-30,650
BTSG icon
81
BrightSpring Health Services
BTSG
$11.7B
$2.13M 0.26%
50,000
-148,000
XENE icon
82
Xenon Pharmaceuticals
XENE
$4.95B
$1.63M 0.2%
28,000
-111,000
ALGN icon
83
Align Technology
ALGN
$12.3B
$1.29M 0.16%
7,500
-91,500
NVCR icon
84
NovoCure
NVCR
$1.95B
$763K 0.09%
+70,000
ATEC icon
85
Alphatec Holdings
ATEC
$1.22B
$762K 0.09%
70,000
+50,000
CMPX icon
86
Compass Therapeutics
CMPX
$364M
$609K 0.08%
+115,113
APLS
87
DELISTED
Apellis Pharmaceuticals
APLS
– –
-374,450
BNTX icon
88
BioNTech
BNTX
$21.6B
– –
-20,870
BRKR icon
89
Bruker
BRKR
$8.56B
– –
-147,315
CNC icon
90
Centene
CNC
$32.1B
– –
-46,231
CNTA
91
Centessa Pharmaceuticals
CNTA
$6.14B
– –
-100,000
CYTK icon
92
Cytokinetics
CYTK
$9.22B
– –
-44,375
INSP icon
93
Inspire Medical Systems
INSP
$1.21B
– –
-35,800
IRTC icon
94
iRhythm Holdings
IRTC
$3.52B
– –
-7,000
JANX icon
95
Janux Therapeutics
JANX
$824M
– –
-225,377
PEN icon
96
Penumbra
PEN
$12.6B
– –
-31,500
PRVA icon
97
Privia Health
PRVA
$2.7B
– –
-125,000
QURE icon
98
uniQure
QURE
$1.7B
– –
-79,375
RDNT icon
99
RadNet
RDNT
$4.26B
– –
-47,000
RYTM icon
100
Rhythm Pharmaceuticals
RYTM
$5.89B
– –
-35,000
1 2 3
4
5